The March 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection provides complementary materials for the following chapters:
Chapter 5 – HIV diagnosis and ARV drugs for HIV prevention, including self-testing and early infant diagnosis
Chapter 7 – Antiretroviral therapy, including optimizing ART for children and adults and the use of CD4 testing
Chapter 9 – Guidance on operations and service delivery, including rolling out viral load testing, procurement and supply chain management concerns and community models of ART delivery
Chapter 11 – Monitoring and evaluation, including surveillance of ARV drug toxicity monitoring and surveillance of drug resistance
The World Health Organization (WHO) will issue the next supplement to the consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection in the second half of 2014. This later supplement will include sections related to diagnosing and managing major opportunistic and other HIV-associated infections as well as on adherence and retention. Future supplements will address the interactions between HIV and noncommunicable diseases, mental health and nutrition.